发明授权
US08022174B2 C-type lectin transmembrane antigen expressed in human prostate cancer and uses therof
失效
C型凝集素跨膜抗原在人类前列腺癌中表达并使用
- 专利标题： C-type lectin transmembrane antigen expressed in human prostate cancer and uses therof
- 专利标题（中）： C型凝集素跨膜抗原在人类前列腺癌中表达并使用
-
申请号： US12572200申请日： 2009-10-01
-
公开(公告)号： US08022174B2公开(公告)日： 2011-09-20
- 发明人: Daniel E. H. Afar , Rene S. Hubert , Aya Jakobovits , Arthur B. Raitano
- 申请人： Daniel E. H. Afar , Rene S. Hubert , Aya Jakobovits , Arthur B. Raitano
- 申请人地址： US CA Santa Monica
- 专利权人： Agensys, Inc.
- 当前专利权人： Agensys, Inc.
- 当前专利权人地址： US CA Santa Monica
- 代理机构： Morrison & Foerster LLP
- 主分类号： C07K2/00
- IPC分类号： C07K2/00
摘要：
A novel gene (designated PC-LECTIN) that is highly overexpressed in prostate cancer and its encoded protein is described. PC-LECTIN in normal human tissues is restricted to testis, but is highly expressed in prostate cancer. Consequently, PC-LECTIN provides a diagnostic and/or therapeutic target for prostate cancer.
公开/授权文献
信息查询
